Stage 0 Pancreatic Cancer American Joint Committee on Cancer v8
1 clinical trials · Condition
◉ Watch Stage 0 Pancreatic Cancer American Joint Committee on Cancer v8
| Record | Firm | Date |
|---|---|---|
| NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer (NCT04539808) | OHSU Knight Cancer Institute | 2021-05-27 |
Track Stage 0 Pancreatic Cancer American Joint Committee on Cancer v8 automatically
Every clearance here is in the API, with alerts when new ones post.